Cargando…

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma

BACKGROUND: Despite the rise in the use of immune checkpoint blockade drugs (ICBs) in recent years, there are no ICB drugs that are currently approved or under large-scale clinical trials for glioblastoma (GBM). T-cells, which mainly mediate adaptive immunity, are an important part of the tumor immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Zihao, Chu, Siwen, Zhu, Chen, Han, Yunhe, Liang, Qingyu, Shen, Shuai, Cheng, Wen, Wu, Anhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Bioinformatics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710057/ https://www.ncbi.nlm.nih.gov/pubmed/35036121 http://dx.doi.org/10.7717/peerj.12547

Ejemplares similares

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

ENPEP as a potential predictor of immune checkpoint inhibitor efficacy
por: Wang, Aoyun, et al.
Publicado: (2021)

Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma
por: Gao, Guangtao, et al.
Publicado: (2021)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis
por: Zhang, Mengyuan, et al.
Publicado: (2022)

An effective fingerprint orientation field estimation method using differential values of grayscale intensity
por: Shen, Ting-Wei, et al.
Publicado: (2023)

Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
por: Zhang, Na, et al.
Publicado: (2020)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2020)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

Computational analysis and verification of molecular genetic targets for glioblastoma
por: Xue, Liang, et al.
Publicado: (2020)

Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling
por: Wei, Yousheng, et al.
Publicado: (2020)

Pan‐cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors
por: Jiang, Junjie, et al.
Publicado: (2021)

MMP12 serves as an immune cell–related marker of disease status and prognosis in lung squamous cell carcinoma
por: Zhang, Wei, et al.
Publicado: (2023)

Immune‐relatedlncRNAs can predict the prognosis of acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2021)

Reduced GRAMD1C expression correlates to poor prognosis and immune infiltrates in kidney renal clear cell carcinoma
por: Hao, Haiyan, et al.
Publicado: (2019)

Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung
por: Miao, Huikai, et al.
Publicado: (2021)

Construction of an immune-related signature with prognostic value for colon cancer
por: Lv, Yunxia, et al.
Publicado: (2021)

Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas
por: Ma, Bo, et al.
Publicado: (2020)

Mining of prognosis-related genes in cervical squamous cell carcinoma immune microenvironment
por: Ma, Jiong, et al.
Publicado: (2020)

Significant correlation between HSPA4 and prognosis and immune regulation in hepatocellular carcinoma
por: Shang, Bing-Bing, et al.
Publicado: (2021)

Analysis of core genes for colorectal cancer prognosis based on immune and stromal scores
por: Zhu, Yi, et al.
Publicado: (2021)

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients
por: Liu, Feng, et al.
Publicado: (2022)

The landscape and prognostic value of tumor-infiltrating immune cells in gastric cancer
por: Li, Linhai, et al.
Publicado: (2019)

Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma
por: Zhu, Yueyan, et al.
Publicado: (2019)

Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma
por: Qiu, Chen, et al.
Publicado: (2021)

A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma
por: Wu, Zhengyuan, et al.
Publicado: (2021)

A robust immune-related lncRNA signature for the prognosis of human colorectal cancer
por: Zhu, Gongmin, et al.
Publicado: (2022)

Lymph node status and its impact on the prognosis of left‐sided and right‐sided colon cancer: A SEER population‐based study
por: Huang, Yadi, et al.
Publicado: (2021)

Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer
por: Wang, Qiaoyun, et al.
Publicado: (2020)

LncRNAs specifically overexpressed in endocervical adenocarcinoma are associated with an unfavorable recurrence prognosis and the immune response
por: Song, Yong, et al.
Publicado: (2021)

The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
por: Peng, Bi, et al.
Publicado: (2021)

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients
por: Hu, Yan, et al.
Publicado: (2021)

Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer
por: Yu, Zeying, et al.
Publicado: (2022)

High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration
por: Wang, Hai yue, et al.
Publicado: (2023)

Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation
por: Wu, Xuan, et al.
Publicado: (2023)

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors
por: Suntiparpluacha, Monthira, et al.
Publicado: (2023)

Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma
por: Lan, Hua, et al.
Publicado: (2021)

The hypoxia-associated genes in immune infiltration and treatment options of lung adenocarcinoma
por: Liu, Liu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n6docgdp9a4nam3jj116vb60ir